Cheryl Reicin will speak at the University of Toronto’s Translational Research Program’s Rapid approvals—COVID pivots, models and sustainability webinar on November 3.
The session unpacks the process of “translating research into commercialization” and how the pandemic has resulted in several expedited approvals and implementations of innovations. Cheryl and the other panelists will discuss the “benefits and shortcomings of pathways, pivots, successes, and failures of go-to-market strategies during COVID” and share which key learnings the sector can take into a post-pandemic world.
You can register for the webinar on the University of Toronto’s website.
